Unknown OBSERVATIONAL NCT00519454

Estrogen and Gender Biased Autoimmunity

Estrogen and Gender Biased Autoimmunity in Systemic Lupus Erythematosus

Sponsor: AstraZeneca

Updated 6 times since 2017 Last updated: Sep 3, 2010 Started: Apr 30, 2005 Primary completion: Dec 31, 2013 Completion: Dec 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Systemic Lupus Erythematosus, this trial is ongoing. The trial is conducted by AstraZeneca and has accumulated 6 data snapshots since 2005. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Jun 2018 — Jan 2021 [monthly]

Unknown Status
Apr 2018 — Jun 2018 [monthly]

Unknown Status

Phase: NA → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Unknown Status NA

First recorded

Apr 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

AstraZeneca
The Center for Rheumatic Disease, Allergy, & Immunology

Data source: The Center for Rheumatic Disease, Allergy, & Immunology

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kansas City, United States